drugset / Trial / NCT00409929
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of AEB071
RandomizedParallel-groupDouble-blindTreatment
Summary
This study will evaluate the safety and tolerability of ascending single oral doses greater than 500 mg of AEB071 in healthy subjects
Timeline
- Start
- 2006-06
- Primary completion
- 2006-07
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | sotrastaurin | Small molecule | — | Oral |
Indications
No indication recorded.